Sign-up for our newsletter
MAIN
Event Calendar
Awardee Reports
ABOUT DIACOMP
Citing DiaComp
Contact
Committees
Institutions
Awardee Reports
Publications
Bioinformatics
RESOURCES
Protocols & Methods
Reagents & Resources
Mouse Diet
Breeding Schemes
Validation Criteria
IMPC / KOMP Data
Publications
Bioinformatics
CONTACT
PARTICIPANT AREA
Login
▹
Publications
▹
Home
Publication
The relationship between immunity and metabolism in Drosophila diet-induced
insulin resistance.
Authors
Musselman LP, Fink JL, Grant AR, Gatto JA, Tuthill BF, Baranski TJ
Submitted By
Laura Musselman on 11/1/2017
Status
Published
Journal
Molecular and cellular biology
Year
2017
Date Published
10/30/2017
Volume : Pages
Not Specified
:
Not Specified
PubMed Reference
29084810
Abstract
Systemic and tissue-specific insulin resistance have been described in
Drosophila, and are accompanied by many indicators of metabolic disease. The
downstream mediators of insulin-resistant pathophysiology remain unclear. We
analyzed insulin signaling in the fat body using loss- and gain-of-function.
When expression of the sole Drosophila Insulin receptor (InR) was reduced in
larval fat bodies, animals exhibited developmental delay and reduced size in a
diet-dependent manner. Fat body InR knockdown also led to reduced survival on
high-sugar diets. To look downstream of InR at potential mediators of insulin
resistance, RNA-seq studies in insulin-resistant fat bodies revealed
differential expression of genes, including those involved in innate immunity.
Obesity-associated insulin resistance led to increased susceptibility of flies
to infection, as in humans. Reduced innate immunity was dependent on fat body
InR expression. The peptidoglycan recognition proteins (PGRPs) PGRP-SB2 and
PGRP-SC2 were selected for further study based on differential expression
studies. Downregulating PGRP-SB2 selectively in the fat body protected animals
from the deleterious effects of overnutrition, whereas downregulating PGRP-SC2
produced InR-like phenotypes. These studies extend earlier work linking the
immune and insulin signaling pathways and identify new targets of insulin
signaling that could serve as potential drug targets to treat type 2 diabetes.
Investigators with authorship
Name
Institution
Laura Musselman
SUNY at Binghamton
Complications
All Complications
Bioinformatics
Bone
Cardiomyopathy
Cardiovascular
Gastro-Intestinal (GI)
Nephropathy
Neuropathy & Neurocognition
Pediatric Endocrinology
Retinopathy
Uropathy
Wound Healing
Welcome to the DiaComp Login / Account Request Page.
Email Address:
Password:
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
click here.
ERROR!
There was a problem with the page:
User Info
User Confirm
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!